Loading
No insider purchase over the last 90 days. The latest, by Sean Smith, was filed 17 Sept 2025.
Eden Research plc: what insiders have been doing
Eden Research plc belongs to the Chemicals sector. Filings by its managers are published through RNS (LSE). 2 insiders have disclosed 2 filings since 22 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Eden Research plc for at least a year.
Across the 832 companies tracked on its exchange, the median is 6 filings; at 2 filings, this issuer sits below that mark. Looking back to 2016, when coverage begins, insiders filed 21 purchases and 1 sale.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Insider Decl.
24
Thresholds
n/a
Buy Volume
€150,621
21 ops. · all time
Sell Volume
€18,334
1 ops. · all time
Who traded when
BuySaleAlex Abrey4 buys
Sean Smith4 buys
Derek McAllan2 buys
Lykele van der Broek2 buys
Since the insiders bought
- -16.1%Entry £0.04 · Close at T+365 £0.04
- -64.5%Entry £0.10 · Close at T+365 £0.04
- +0.7%Entry £0.08 · Close at T+365 £0.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,073 of 26,320 companies
24.1
score / 100
Value14
Quality35
FCF yld-18%
Earn yld-9.7%
EV/EBITDA·
ROE·
Gross mgn44%
Net mgn-44%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
£0.02
Analyst consensus
1 analysts0.00/5
£0.20Target £0.20(+716%)£0.20
Income statement
Revenue£4.3M
Gross profit£1.9M44% margin
EBITDA-£1.6M-37% margin
Net income-£1.9M-50.4% margin
Valuation
P/Book122.5x
Beta1.74
Balance sheet & cash
Market cap£19.7M
Total debt£168.7k
Free Cash Flow-£3.6M
Debt / Equity5%
Profitability & ownership
% insiders11.2%
% institutions64.1%
Last declaration on 17 September 2026
Declarations24 total
7,101,189 shares@ £0.010.36% mcap100.0% of flowOutside of trading venueISIN GB0001646941RNS:9776268-0
5,334,928 shares@ £0.010.27% mcap100.0% of flowOutside of trading venueISIN GB0001646941RNS:9776268-1
0London Stock ExchangeISIN GB0001646941RNS:5824512
Canonical exit: 16 Dec 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5824339
Canonical exit: 16 Dec 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5598761-0
Canonical exit: 30 Jun 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5598761-1
Canonical exit: 30 Jun 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5562414
Canonical exit: 3 Jun 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5561774
Canonical exit: 2 Jun 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5560696-0
Canonical exit: 2 Jun 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5560696-1
Canonical exit: 2 Jun 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5529720
Canonical exit: 7 May 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5517188-1
Canonical exit: 28 Apr 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5517188-0
Canonical exit: 28 Apr 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5517188-2
Canonical exit: 28 Apr 2025 (T+90)
0London Stock ExchangeISIN GB0001646941RNS:5260555
Canonical exit: 8 Oct 2024 (T+90)
317,522 shares@ £0.047222.0% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:4389291
Canonical exit: 29 Aug 2022 (T+90)
180,000 shares@ £0.1020.3% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:4060321
Canonical exit: 26 Oct 2021 (T+90)
114,313 shares@ £0.083100.0% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:LSE20191016124841_14268620_20200326185154062_18880
Canonical exit: 14 Jan 2020 (T+90)
50,000 shares@ £0.10112.2% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:LSE20190416124331_14043255_20200326185042809_11461-0
Canonical exit: 15 Jul 2019 (T+90)
92,848 shares@ £0.11921.7% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:LSE20180713102314_13717217_20200330111420516_14794-0
Canonical exit: 11 Oct 2018 (T+90)
304,664 shares@ £0.122287.8% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:LSE20180713102314_13717217_20200330111420516_14794-1
Canonical exit: 11 Oct 2018 (T+90)
213,921 shares@ £0.1459.3% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:LSE20180619070012_13684479_20200330111423723_11862
Canonical exit: 16 Sept 2018 (T+90)
115,000 shares@ £0.140527.7% of flowLSE, AIM Market (XLON)ISIN GB0001646941FCA-NSM:LSE20180510170442_13637013_20200330111431955_17429
47,000 shares@ £0.104100.0% of flowFCA-NSM:LSE20160526153628_012831521_20200330143610166_20096
Canonical exit: 24 Aug 2016 (T+90)
24 of 24 declarations
About Eden Research plc
Eden Research plc is a company focused on developing biocontrol solutions and crop protection products. It emphasizes sustainable alternatives for agriculture.
